Ziana gel review: two active ingredients, one acne-specific prescription

Identify the exact medicine before comparing offers

The DailyMed Ziana record was updated May 15, 2026; the prescribing information is revised March 2026. It identifies clindamycin phosphate 1.2% with tretinoin 0.025% in a topical gel, with 30 g and 60 g tubes listed. The label records initial US approval in 2006.

Its indication is acne vulgaris in patients aged 12 and older. The reviewed indication is not facial wrinkle reduction, general rejuvenation or rosacea. An older adult looking for a fine-line product should not infer that every prescription containing tretinoin addresses the same goal. A familiar active ingredient does not make the accompanying antibiotic a neutral addition.

Our Retin-A cream review concerns a different finished medicine, while Altreno is a separately labeled lotion. Strength numbers, vehicles and active combinations belong together in a comparison. This review does not suggest replacing one prescription with another or adding Ziana to a prescription already in use.

Read the success definition before the percentage

The label describes three randomized, blinded, 12-week acne studies. In the combined first two studies, 21% of Ziana participants were assessed as clear or almost clear at week 12, versus 8% with vehicle. In the third study, the reported 41% success result meant at least a two-grade improvement, versus 34% with clindamycin gel. These are different definitions of success.

A headline that treats the third study’s percentage as a complete-clearance rate would misread the table. Likewise, a reduction in lesion counts is not the proportion of people whose acne disappeared. Keeping the endpoint attached to the number makes the result understandable without making the finding larger or smaller than the source actually reports.

The studies do not compare Ziana with CoreAge Rx, and they do not establish a wrinkle outcome. The label also notes insufficient participants aged 65 and older to determine whether their response differed from younger participants. That is a population limit, not proof that the medicine fails after 65 or that the findings automatically apply unchanged to every older reader.

The antibiotic warning deserves its own conversation

Clindamycin’s precautions are not limited to facial dryness. The label contraindicates Ziana in people with regional enteritis, ulcerative colitis or a history of antibiotic-associated colitis. Its patient information names Crohn’s disease. A gastrointestinal history therefore belongs in the consultation even though the medicine is applied to the skin.

The label warns about diarrhea and colitis after topical clindamycin exposure. It directs discontinuation if significant diarrhea occurs and tells patients with severe watery or bloody diarrhea to stop and contact their doctor. These symptoms should not be folded into a generic retinoid adjustment story or left until an ordinary cosmetic follow-up appointment.

MedlinePlus’s clindamycin information provides additional patient context for the antibiotic component. The practical question is whether the prescriber has reviewed the relevant history and explained the response to concerning symptoms. A website’s suggestion that a gel feels lightweight cannot answer that safety question.

Check the complete treatment plan

Ziana can cause local irritation, and its label addresses sun exposure and sunburn. It also says it should not be used with erythromycin-containing products. Tell the prescriber about medicines and skincare from other services, including products that seem unrelated to the current consultation. This article is not a complete interaction screen.

The AAD’s acne guideline summary recommends benzoyl peroxide alongside topical or oral antibiotics to help prevent resistance. Ziana itself contains no benzoyl peroxide. That is a question for the prescriber about the whole plan, not an instruction from this review to layer another active onto the gel or to select an application schedule.

Our antibiotic discussion explains the difference between a combination product and an antibiotic-management plan. Follow the exact prescription and ask how and when it will be reviewed. The existence of a twelve-week study does not independently set every patient’s treatment length, refill authorization or maintenance strategy.

Keep pregnancy, redness and ordinary instructions separate

Tell the prescribing clinician about pregnancy, pregnancy plans and breastfeeding before treatment decisions. Our pregnancy-planning guide discusses the topical tretinoin evidence and avoidance advice without borrowing an oral isotretinoin risk estimate. An old pregnancy letter category in a label is not a self-assessment tool or a reason to assume the combination is suitable.

The facial-redness guide addresses another boundary: acne-like bumps and redness can require assessment beyond selecting a stronger tretinoin product. A patient should not diagnose rosacea from this review, but neither should persistent symptoms automatically be called purging. The exact concern needs to remain part of the consultation.

If Ziana is prescribed, read the supplied patient leaflet and ask about anything that differs from the online record. This review deliberately does not substitute a dosing plan for those instructions. The named product, current package and clinician’s directions are more useful than a generic evening routine copied from another person.

What the public record does not price

We did not verify current branded stock, a pharmacy cash price, insurance coverage or a coupon eligibility decision. A DailyMed package listing is not a live inventory feed. Generic clindamycin–tretinoin products may appear in a pharmacy search, but a substitution and its supplied label need to be confirmed with the pharmacist rather than assumed from a similar name.

The cost guide separates a medication quote from consultation fees and subscription terms. The CoreAge review describes a different commercial route with unresolved public concentrations. Ziana’s useful distinction here is a named, acne-labeled antibiotic–retinoid gel with specific evidence and warnings, not a verified bargain or a universal upgrade to an anti-aging cream.